Students will learn about markets related to healthcare, insurance, biopharmaceuticals, and medical devices. Examine economic issues, models and quantitative analysis related to firms' activities in areas such as innovation, R&D expenditures, patenting, pricing, mergers and acquisitions, and competition in markets. Examine the role played by health insurance systems. Study the economic implications of regulations, such as those by the U.S. FDA. Economic and policy aspects will be examined within the context of the U.S. healthcare sector, along with selected comparisons to European national healthcare systems.
| Spring | Summer | Fall | ||
|---|---|---|---|---|
| (Session 1) | (Session 2) | |||
| 2023 |
Econ Of Biotech & Med Innov (4c)
|
|||
| 2022 |
Econ Of Biotech & Med Innov (4c)
|
|||
| 2021 |
Econ Of Biotech & Med Innov (4c)
|
Econ Of Biotech & Med Innov (4c)
|
Econ Of Biotech & Med Innov (4c)
|
|
| 2020 |
Econ Of Biotech & Med Innov (4c)
|
|||
| 2019 | ||||
| 2018 | ||||
| 2017 | ||||
| 2016 | ||||
| 2015 | ||||
| 2014 | ||||
| 2013 | ||||
| 2012 | ||||
| 2011 | ||||
| 2010 | ||||
| 2009 | ||||
| 2008 | ||||
| 2007 | ||||
| 2006 | ||||
| 2005 | ||||
| 2004 | ||||
| 2003 | ||||
| 2002 | ||||
| 2001 | ||||
| 2000 | ||||
| 1999 | ||||
| 1998 | ||||